There have been 50 recent insider transactions recorded for Zentalis Pharmaceuticals, Inc. (ZNTL), including 28 buys and 16 sells. Total insider buying was valued at $26.73M and total insider selling at $10.59M.
Notable insiders with recent activity include Vultaggio Vincent, Eastland Julia Marie, Bruns Ingmar. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — ZNTL
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-10 |
Vultaggio Vincent |
Pao and Pfo |
Informative Sell |
6,894 |
$2.42 |
$16.7K |
146,506 |
| 2026-02-09 |
Eastland Julia Marie |
CEO & President |
Informative Sell |
889 |
$2.39 |
$2.13K |
79,133 |
| 2026-02-09 |
Bruns Ingmar |
Chief Medical Officer |
Informative Sell |
335 |
$2.39 |
$801.62 |
33,332 |
| 2026-02-09 |
Vultaggio Vincent |
Pao and Pfo |
Informative Sell |
3,379 |
$2.39 |
$8.09K |
153,400 |
| 2026-02-06 |
Eastland Julia Marie |
CEO & President |
Informative Sell |
7,866 |
$2.43 |
$19.11K |
80,022 |
| 2026-02-06 |
Bruns Ingmar |
Chief Medical Officer |
Informative Sell |
2,962 |
$2.43 |
$7.2K |
33,667 |
| 2026-02-06 |
Vultaggio Vincent |
Pao and Pfo |
Informative Sell |
29,951 |
$2.43 |
$72.77K |
156,779 |
| 2026-02-03 |
Vultaggio Vincent |
Pao and Pfo |
Informative Sell |
556 |
$2.52 |
$1.4K |
186,730 |
| 2026-02-02 |
Vultaggio Vincent |
Pao and Pfo |
Informative Sell |
2,540 |
$2.55 |
$6.48K |
187,286 |
| 2026-01-08 |
Eastland Julia Marie |
CEO & President |
RSU Award |
775,000 |
$2.84 |
$2.2M |
775,000 |
| 2026-01-08 |
Bucher James B |
Chief Legal Officer |
RSU Award |
100,000 |
$2.84 |
$284K |
100,000 |
| 2026-01-08 |
Bruns Ingmar |
Chief Medical Officer |
RSU Award |
365,000 |
$2.84 |
$1.04M |
365,000 |
| 2026-01-08 |
Vultaggio Vincent |
Pao and Pfo |
RSU Award |
100,000 |
$2.84 |
$284K |
100,000 |
| 2025-12-31 |
Walters Group |
10 Percent Owner |
Informative Buy |
6,459,973 |
$1.20 |
$7.75M |
13,509,973 |
| 2025-12-15 |
Walters Group |
10 Percent Owner |
Unknown |
- |
- |
- |
7,050,000 |
| 2025-12-15 |
Matrix Capital Management Company, Lp |
10 Percent Owner |
Informative Sell |
7,500,000 |
$1.33 |
$9.98M |
6,459,973 |
| 2025-10-01 |
Bucher James B |
Chief Legal Officer |
RSU Award |
400,000 |
$1.54 |
$616K |
400,000 |
| 2025-09-18 |
Bucher James B |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-17 |
Myers Scott Dunseth |
Director |
RSU Award |
57,603 |
- |
- |
338,795 |
| 2025-06-17 |
Walker Luke Nathaniel |
Director |
RSU Award |
57,603 |
- |
- |
144,284 |
| 2025-06-17 |
Johnson David Michael |
Director |
RSU Award |
57,603 |
- |
- |
250,421 |
| 2025-06-17 |
Skvarka Jan |
Director |
RSU Award |
57,603 |
- |
- |
207,154 |
| 2025-06-17 |
Kariuki Enoch |
Director |
RSU Award |
57,603 |
- |
- |
137,365 |
| 2025-04-30 |
Myers Scott Dunseth |
Director |
Informative Buy |
21,000 |
$1.40 |
$29.37K |
281,192 |
| 2025-02-06 |
Bruns Ingmar |
Chief Medical Officer |
Informative Buy |
20,000 |
$2.28 |
$45.66K |
36,629 |
| 2025-02-03 |
Eastland Julia Marie |
CEO & President |
RSU Award |
59,388 |
$1.68 |
$99.77K |
59,388 |
| 2025-02-03 |
Lackner Mark |
Chief Scientific Officer |
RSU Award |
124,714 |
$1.68 |
$209.52K |
124,714 |
| 2025-02-03 |
Bruns Ingmar |
Chief Medical Officer |
RSU Award |
16,629 |
$1.68 |
$27.94K |
16,629 |
| 2025-02-03 |
Paul Andrea |
Chief Legal Officer |
RSU Award |
124,714 |
$1.68 |
$209.52K |
124,714 |
| 2025-02-03 |
Vultaggio Vincent |
Pao and Interim Pfo |
RSU Award |
35,633 |
$1.68 |
$59.86K |
35,633 |
| 2025-01-31 |
Eastland Julia Marie |
CEO & President |
Informative Buy |
28,500 |
$1.73 |
$49.34K |
28,500 |
| 2025-01-31 |
Walker Luke Nathaniel |
Director |
Informative Buy |
14,200 |
$1.76 |
$24.97K |
86,681 |
| 2025-01-31 |
Skvarka Jan |
Director |
Informative Buy |
60,000 |
$1.72 |
$103.45K |
149,551 |
| 2025-01-02 |
Lackner Mark |
Chief Scientific Officer |
Informative Sell |
4,411 |
$3.12 |
$13.76K |
191,317 |
| 2024-12-02 |
Eastland Julia Marie |
CEO & President |
RSU Award |
3,028,800 |
$3.66 |
$11.09M |
3,028,800 |
| 2024-12-02 |
Bruns Ingmar |
Chief Medical Officer |
RSU Award |
712,650 |
$3.66 |
$2.61M |
712,650 |
| 2024-11-13 |
Myers Scott Dunseth |
Director |
Unknown |
- |
- |
- |
- |
| 2024-11-13 |
Myers Scott Dunseth |
Director |
RSU Award |
260,192 |
- |
- |
260,192 |
| 2024-11-13 |
Eastland Julia Marie |
CEO & President |
Unknown |
- |
- |
- |
- |
| 2024-11-13 |
Bruns Ingmar |
Officer |
Unknown |
- |
- |
- |
- |
| 2024-10-04 |
Vultaggio Vincent |
Principal Accounting Officer |
Informative Sell |
1,603 |
$3.18 |
$5.1K |
33,855 |
| 2024-06-21 |
Johnson David Michael |
Director |
RSU Award |
48,429 |
- |
- |
192,818 |
| 2024-06-21 |
Skvarka Jan |
Director |
RSU Award |
41,581 |
- |
- |
89,551 |
| 2024-06-21 |
Kariuki Enoch |
Director |
RSU Award |
41,581 |
- |
- |
79,762 |
| 2024-05-31 |
Gallagher Cam |
President, Interim CFO |
Informative Sell |
9,597 |
$11.98 |
$114.97K |
633,680 |
| 2024-05-24 |
Walker Luke Nathaniel |
Director |
Unknown |
- |
- |
- |
- |
| 2024-05-24 |
Walker Luke Nathaniel |
Director |
RSU Award |
72,481 |
- |
- |
72,481 |
| 2024-05-09 |
Hausman Diana |
Chief Medical Officer |
Informative Sell |
3,356 |
$12.62 |
$42.35K |
373,876 |
| 2024-04-05 |
Vultaggio Vincent |
Principal Accounting Officer |
Disposition |
25,000 |
$11.69 |
$292.25K |
- |
| 2024-02-12 |
Gallagher Cam |
President |
Informative Sell |
1,173 |
$11.44 |
$13.42K |
643,277 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
